221 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
over the past year have positioned the Company for long-term success and profitability,” said Craig Collard, Chief Executive Officer of Heron. “I am
8-K
EX-10.1
HRTX
Heron Therapeutics Inc
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
, long-term debt, net current assets or short-term debt of the Company or its Subsidiary or any adverse change, or any development involving a prospective
8-K
EX-99.2
aq31 c1fd5n2ipw3p5b
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
S-8
EX-99.2
wvuzzxjn 530r9
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-99.1
fo05cds
30 Jun 23
Registration of securities for employees
4:06pm
8-K
EX-99.1
7xzx04wg
23 Jun 23
Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
4:19pm
8-K
EX-99.1
l24 wcar4tbz
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm
S-8
EX-99.2
u9jky8 ew8tyxr
9 Sep 22
Registration of securities for employees
4:06pm
S-8
EX-99.1
15bi0u l3
9 Sep 22
Registration of securities for employees
4:06pm
8-K
EX-10.1
7ulr hqhwsmw
10 Aug 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
227 mopjmjxs
9 Aug 22
Results of Operations and Financial Condition
8:20am
8-K
bot4yukq84ew6kte0
30 Jun 22
Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
8:40am